Progress in non-operative treatment for seborrheic keratosis

doi:10.3760/cma.j.issn.1007-1245.2022.14.032

Abstract

Abstract: Seborrheic keratosis (SK) is a common benign epidermal tumor that occurs in adults, with almost no malignant transformation. However, it is easy to be confused with other skin tumors, and surgical resection and histopathological examination are required when the diagnosis is not clear. People often seek medical removal of skin lesions for cosmetic purposes. Drugs, ultrasound, laser, photodynamic therapy (PDT), nanosecond electric field, hyperbaric oxygen, and acupuncture are also effective besides surgical excision. This article summarizes the recent non-surgical treatments for SK.

Key words: Seborrheic keratosis, Physiotherapy, Topical administration, Removal

摘要： 脂溢性角化病是一种常见的发生于成年人的良性表皮肿瘤，几乎不恶变，但易与其他皮肤病混淆，诊断不明时须手术切除并行组织病理检查。人们多出于美容目的而治疗，除手术切除外，药物、超声、激光、光动力、纳秒电场、高压氧、火针等亦能有效清除皮损。本文总结了近年来治疗脂溢性角化病的非手术方法。

关键词: 脂溢性角化病, 物理治疗, 外涂, 清除

Hu Zhongzhu, Lei Tiechi. Progress in non-operative treatment for seborrheic keratosis [J]. International Medicine and Health Guidance News, 2022, 28(14): 2066-2069.

胡中柱雷铁池. 脂溢性角化病的非手术治疗进展[J]. 国际医药卫生导报, 2022, 28(14): 2066-2069.

References

[1] Neel VA, Todorova K, Wang J, et al. Sustained akt activity is required to maintain cell viability in seborrheic keratosis, a benign epithelial tumor[J]. J Invest Dermatol, 2016, 136(3): 696-705. DOI: 10.1016/j.jid.2015.12.023.
[2] Cheong KA, Kil IS, Ko HW, et al. Upregulated guanine deaminase is involved in hyperpigmentation of seborrheic keratosis via uric acid release[J]. Int J Mol Sci, 2021, 22(22): 12501. DOI: 10.3390/ijms222212501.
[3] Yamanaka-Takaichi M, Sugawara K, Sumitomo R, et al. The mast cell-scf-cb1 interaction is a key player in seborrheic keratosis[J]. J Histochem Cytochem, 2020, 68(7): 461-471. DOI: 10.1369/0022155420938031.
[4] Li Y, Wang Y, Zhang W, et al. Overexpression of amyloid precursor protein promotes the onset of seborrhoeic keratosis and is related to skin ageing[J]. Acta Derm Venereol, 2018, 98(6): 594-600. DOI: 10.2340/00015555-2911.
[5] Prince GT, Cameron MC, Fathi R, et al. Topical 5-Fluorouracil in dermatologic disease [J]. Int J Dermatol, 2018, 57(10): 1259-1264. DOI: 10.1111/ijd.14106.
[6] Goodhead C, Hampton P. Actikerall: an alternative to curettage for some seborrhoeic keratoses?[J]. Clin Exp Dermatol, 2018, 43(2): 198-200. DOI: 10.1111/ced.13301.
[7] Komalasari DN, Djawad K, Nurdin AR, et al. Unusual clinical manifestation of seborrheic keratosis on the scalp successfully treated with topical trichloroacetic acid: an atypical case report [J]. Pan Afr Med J, 2020, 37: 98. DOI: 10.11604/pamj.2020.37.98.26090.
[8] O'connor AA, Lowe PM, Shumack S, et al. Chemical peels: a review of current practice [J]. Australas J Dermatol, 2018, 59(3): 171-181. DOI: 10.1111/ajd.12715.
[9] Perkins SW, Gibson FB. Medium-depth peels [J]. Facial Plast Surg, 1995, 11(1): 22-29. DOI: 10.1055/s-2008-1064513.
[10] Lacarrubba F, Nasca MR, Verzì AE, et al. A novel topical agent in the treatment of seborrheic keratoses: a proof of concept study by clinical and dermoscopic evaluation[J]. Dermatol Ther, 2017, 30(5): e12526. DOI: 10.1111/dth.12526.
[11] Tribó MJ, Aladren S, Garre A, et al. A novel Nitrizinc Complex® solution for topical treatment of seborrhoeic keratosis: an interventional clinical study [J]. Eur J Dermatol, 2019, 29(2): 203-208. DOI: 10.1684/ejd.2019.3525.
[12] Bito T, Izu K, Tokura Y. Evaluation of toxicity and stat3 activation induced by hydrogen peroxide exposure to the skin in healthy individuals [J]. J Dermatol Sci, 2010, 58(2): 157-159. DOI: 10.1016/j.jdermsci.2010.03.013.
[13] Yang H, Xie Y, Yang D, et al. Oxidative stress-induced apoptosis in granulosa cells involves JNK, P53 and Puma[J]. Oncotarget, 2017, 8(15): 25310-25322. DOI: 10.18632/oncotarget.15813.
[14] Chen Z, Wang C, Yu N, et al. Inf2 regulates oxidative stress-induced apoptosis in epidermal hacat cells by modulating the HIF1 signaling pathway [J]. Biomed Pharmacother, 2019, 111:151-161. DOI: 10.1016/j.biopha.2018.12.046.
[15] Kao S, Kiss A, Efimova T, et al. Ex vivo evaluation of cytotoxicity and melanocyte viability after a-101 hydrogen peroxide topical solution 40% or cryosurgery treatment in seborrheic keratosis lesions [J]. J Am Acad Dermatol, 2018, 79(4): 767-768. DOI: 10.1016/j.jaad.2018.03.034.
[16] DuBois JC, Jarratt M, Beger BB, et al. A-101, a proprietary topical formulation of high-concentration hydrogen peroxide solution: a randomized, double-blind, vehicle-controlled, parallel group study of the dose-response profile in subjects with seborrheic keratosis of the face[J]. Dermatol Surg, 2018, 44(3): 330-340. DOI: 10.1097/DSS.0000000000001302.
[17] Agrawal D, Adil M, Amin SS, et al. Comparison of efficacy & safety of 30% hydrogen peroxide with 50% trichloroacetic acid in eborrheic keratosis: a randomized controlled study[J]. Ital J Dermatol Venerol, 2021, 156(4):489-495. DOI: 10.23736/S2784-8671.20.06518-9.
[18] Afify AA, Hana MR. Comparative evaluation of topical diclofenac sodium versus topical ibuprofen in the treatment of seborrheic keratosis[J]. Dermatol Ther, 2020, 33(6): e14370. DOI: 10.1111/dth.14370.
[19] Aktaş H, Ergin C, Keseroğlu HÖ. Diclofenac gel may be a new treatment option for seborrheic keratosis[J]. Indian Dermatol Online J, 2016, 7(3): 211-212. DOI: 10.4103/2229-5178.182363.
[20] 叶瑞贤,梁晓冬,邓婕,等. 口服维甲酸在治疗皮肤病的应用[J]. 中国中西医结合皮肤性病学杂志,2020,19(5):497-500. DOI:10.3969/j.issn.1672-0709.2020.05.037.
[21] Hiraishi Y, Hirobe S, Iioka H, et al. Development of a novel therapeutic approach using a retinoic acid-loaded microneedle patch for seborrheic keratosis treatment and safety study in humans[J]. J Control Release, 2013, 171(2): 93-103. DOI: 10.1016/j.jconrel.2013.06.008.
[22] 花志祥, 施健, 林桦. 532Nmq开关nd:Yag激光联合维a酸霜治疗面部脂溢性角化病的疗效[J]. 中国激光医学杂志, 2016, 25(4): 204-207, 230. DOI: 10.13480/j.issn1003- 9430.2016.0204.
[23] 唐静,李惠,曾丹,等. 维生素D与皮肤相关性疾病关系的研究进展[J]. 重庆医学,2016,45(31):4443-4445. DOI:10.3969/j.issn.1671-8348.2016.31.045.
[24] 游志清. 维生素D类似物的临床研究进展[J]. 西南国防医药,2020,30(3):270-272. DOI:10.3969/j.issn.1004-0188. 2020.03.032.
[25] 胡友红,张爱华,易庆阳,等. 0.1%他扎罗汀联合0.005%卡泊三醇软膏治疗脂溢性角化病疗效观察与分析[J]. 中国美容医学,2016,25(3):52-53. DOI:10.15909/j.cnki.cn61-1347/r.001059.
[26] Czyz M. Fibroblast growth factor receptor signaling in skin cancers[J]. Cells, 2019, 8(6):540. DOI: 10.3390/cells8060540.
[27] Cuevas P, Angulo J, Salgüero I, et al. Clearance of seborrhoeic keratoses with topical dobesilate[J]. BMJ Case Rep, 2012, 2012: bcr0120125628. DOI: 10.1136/bcr.01.2012.5628.
[28] Cuevas P, Calvo M, Angulo J, et al. Efficacy of the fibroblast growth factor inhibitor 2,5-dihydroxyphenylsulfonate in basal cell carcinoma: a histopathological and inmunohistochemical study[J]. J Dermatolog Treat, 2011, 22(6): 348-352. DOI: 10.3109/09546634.2010.551108.
[29] Yi F, Zheng X, Fang F, et al. ALA-PDT alleviates the psoriasis by inhibiting JAK signalling pathway[J]. Exp Dermatol, 2019, 28(11): 1227-1236. DOI: 10.1111/exd.14017.
[30] Hua H, Cheng JW, Bu WB, et al. 5-aminolaevulinic acid-based photodynamic therapy inhibits ultraviolet b-induced skin photodamage[J]. Int J Biol Sci, 2019, 15(10): 2100-2109. DOI:10.7150/ijbs.31583.
[31] 安荣真,张俊花,任娜,等. 5-氨基酮戊酸光动力联合多功能电离子预处理治疗顽固性跖疣7例临床观察并文献复习[J]. 国际医药卫生导报,2022,28(8):1158-1161. DOI:10.3760/cma.j.issn.1007-1245.2022.08.029.
[32] Fang S, Zhou Z, Wu Y, et al. Photodynamic therapy combined with carbon dioxide laser for successful treatment of cutaneous squamous cell carcinoma within a long-standing and huge seborrheic keratosis[J]. Photodiagnosis Photodyn Ther, 2021, 36:102536. DOI: 10.1016/j.pdpdt.2021.102536.
[33] Zhang H, Wei G, Zhang C, et al. Aminolevulinate photodynamic therapy (ALA-PDT) for giant seborrheic keratosis of the head: a case report[J]. Photodiagnosis Photodyn Ther, 2020, 32:102015. DOI: 10.1016/j.pdpdt.2020.102015.
[34] Calik J, Zawada T, Bove T. Treatment of superficial benign vascular tumors by high intensity focused ultrasound: observations in two illustrative cases[J]. J Cosmet Dermatol, 2021, 17: 14682. DOI: 10.1111/jocd.14682.
[35] Bove T, Zawada T, Jessen A, et al. Removal of common warts by high-intensity focused ultrasound: an introductory observation [J]. Case Rep Dermatol, 2021, 13(2): 340-346. DOI: 10.1159/000515075.
[36] Calik J, Migdal M, Zawada T, et al. Treatment of seborrheic keratosis by high frequency focused ultrasound - an early experience with 11 consecutive cases [J]. Clin Cosmet Investig Dermatol, 2022, 15:145-156. DOI: 10.2147/CCID.S348106.
[37] Elman-Shina K, Elman M, Efrati S. Inflammatory seborrheic keratosis resolution after hyperbaric oxygen therapy: case presentation and pathophysiology review[J]. Dermatol Reports, 2021, 13(1): 8871. DOI: 10.4081/dr.2021.8871.
[38] Kaufman D, Martinez M, Jauregui L, et al. A dose-response study of a novel method of selective tissue modification of cellular structures in the skin with nanosecond pulsed electric fields[J]. Lasers Surg Med, 2020, 52(4): 315-322. DOI: 10.1002/Lsm.23145.
[39] Hruza GJ, Zelickson BD, Selim MM, et al. Safety and efficacy of nanosecond pulsed electric field treatment of seborrheic keratoses[J]. Dermatol Surg, 2020, 46(9): 1183-1189. DOI: 10.1097/Dss.0000000000002278.
[40] 张军弼,余远遥,陈少君. 火针治疗脂溢性角化病随机对照试验[J]. 中国中西医结合皮肤性病学杂志,2019,18(4):345-347. DOI:10.3969/j.issn.1672-0709.2019.04.018.
[41] Fu ML, Wu XY, Xu P, et al. Efficacy of microplasma radiofrequency versus co2 laser therapy for seborrheic keratoses: a randomized, intraindividual comparative study[J]. Dermatol Surg, 2021, 47(7): 1017-1018. DOI: 10.1097/DSS.0000000000002896.
[42] Nisticò SP, Cannarozzo G, Campolmi P, Et al. Erbium laser for skin surgery: a single-center twenty-five years' experience [J]. Medicines (Basel), 2021, 8(12): 74. DOI: 10.3390/Medicines8120074.
[43] Lipp MB, Angra K, Wu DC. Safety and efficacy of a novel 730 nm picosecond titanium sapphire laser for the treatment of benign pigmented lesions[J]. Lasers Surg Med, 2021, 53(4): 429-434. DOI: 10.1002/lsm.23314.